Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of fugliptin benzoate added to metformin in inadequately controlled type 2 diabetes
ChiCTR2000033616Phase 3Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Fugliptin benzoate + metformin with Placebo + metformin (2 arms). Primary endpoints: HbA1c at Week 24, Fasting blood glucose and 2 more. Started Jun 2020; status: recruiting.
02
Drugs
fotagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2000033616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033616.